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Blood carries a wide array of biomolecules, including nutrients, hormones, and molecules
that are secreted by cells for speciﬁc biological functions. The recent ﬁnding of stable
RNA of both endogenous and exogenous origin in circulation raises a number of questions
and opens a broad, new ﬁeld: exploring the origins, functions, and applications of these
extracellular RNA molecules. These ﬁndings raise many important questions, including:
what are the mechanisms of export and cellular uptake, what is the nature and source of
their stability, what molecules do they interact with in the blood, and what are the possible
biological functions of the circulating RNA? This review summarizes some key recent
developments in circulating RNA research and discusses some of the open questions
in the ﬁeld.
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Coordination of the activities of different cells in the body is vital
for multi-cellular organisms. For this purpose, at least three dif-
ferent types of intercellular communication systems have evolved.
Physical interactions between cells through cell surface protein
engagement like that between receptors and ligands are used to
transmit signals between close, contacting cells (Schonbeck and
Libby, 2001; Chillakuri et al., 2012). Gap junctions can also facili-
tate the transmission of molecular signals between cells (Valiunas
et al., 2005; Wolvetang et al., 2007; Lim et al., 2011). Membrane
nanotubes or cytonemes that extend up to 100 μm in length
are physical connections that also allow communication between
cells that are not immediately adjacent to each other (Gerdes and
Carvalho, 2008). Multi-cellular organisms have also developed a
network of circulating body ﬂuids to deliver nutrients to cells,
remove waste molecules, and transmit signals for “long-distance”
cell–cell and organ–organ communication. The combination of
the circulation systemwith central andperipheral neural networks,
and other short and medium range communication processes,
allows cells and organs in an organism to operate in close con-
cert. Some circulating proteins or peptides are well-known for
their roles as signaling molecules. These include hormones such
as insulin, growth hormone, prolactin, and many other secreted
proteins/peptides. In addition to these well-known examples,
other biomolecules such as nucleic acids are also exported from
cells and are present in various body ﬂuids (Valadi et al., 2007;
Weber et al., 2010), although their potential roles in intercellular
signaling have not been conﬁrmed. While the discovery of circu-
lating extracellular nucleic acid is not new, having been described
as early as 1948 (Mandel and Métais, 1948), there has been a
renewed interest in the function and application of circulating
nucleic acids due to several, diverse recent ﬁndings. These include
the discoveries of fetal DNA in maternal blood (Lo and Chiu,
2012), tumor-derived DNA in circulation (Kohler et al., 2011)
and stable regulatory non-coding RNA (ncRNA) in body ﬂuids
(Cortez et al., 2011).
RNA is generally considered to be an unstable molecule that is
subject to degradation and turnover by ubiquitous RNase activity.
However, intact RNAs of different types, including both protein-
coding RNA (mRNA) and non-coding RNA (ncRNA) have been
detected in circulation (Valadi et al., 2007). Someof theseRNAs are
likely the result of cell lysis through normal cell turnover and are
in the process of degradation, reabsorption, or excretion (Turchi-
novich et al., 2011). However, the abundance and high stability
of some of these RNA molecules, especially the short regulatory
RNA,microRNA(miRNA), suggests a different scenario: the possi-
bility of a cell–cell communication system throughRNA-mediated
signals (Lotvall and Valadi, 2007; Turchinovich et al., 2011; Mon-
tecalvo et al., 2012). Furthermore, recent studies have shown that
exogenous RNA molecules can enter into circulation through the
diet or other means, and can potentially be taken up by cells
and thereby alter the cellular transcriptome (Semenov et al., 2012;
Wang et al., 2012; Zhang et al., 2012a). Many questions remain
unanswered, however, including: what are the sources of endoge-
nous and exogenous RNA molecules in circulation, what is (are)
themechanism(s) bywhich these RNAs enter into circulation, how
are they stabilized there, are they taken up by cells, and how are
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they recognized for uptake by cells? Here we review several recent
developments in the study of circulating RNAs and their potential
functions and possible applications.
EXTRACELLULAR RNA IN BODY FLUIDS
Among all the circulating nucleic acids, miRNAs are probably the
most extensively studied. These smallmolecules are short, ncRNAs
involved in regulating the cellular transcriptome and proteome by
destabilizing mRNA and/or attenuating protein translation (Fil-
ipowicz et al., 2008; Fabian et al., 2010). The interaction between
miRNAs and their cognate mRNA targets is mediated by par-
tial sequence complementarity between the two (Fabian et al.,
2010). The RNA-induced silencing complex (RISC), which con-
tains a number of proteins including members of the Argonaute
family, the RNA recognition motif containing protein TNRC6B,
putative DNA helicase MOV10, among others, is involved in the
miRNA–mRNA interaction (Chendrimada et al., 2007).
MicroRNAs were ﬁrst detected in the blood plasma and serum
in 2008 (Chen et al., 2008; Chim et al., 2008; Hunter et al., 2008;
Lawrie et al., 2008; Mitchell et al., 2008; Skog et al., 2008) and have
subsequently been detected in many other different body ﬂuids
including urine, saliva, tears, and breast milk (Park et al., 2009;
Hanke et al., 2010; Weber et al., 2010). The total amount and the
concentration of individual miRNAs vary widely among the dif-
ferent ﬂuid types (Weber et al., 2010). The potential of circulating
miRNAs as biomarkers has been extensively investigated in recent
years. miRNAs make good biomarker candidates for several rea-
sons. They are stable in body ﬂuids, which are easy to obtain
from patients, they can be easily measured with high sensitivity
because they are ampliﬁable, and some markers and sets of mark-
ers have shown proﬁles associated with speciﬁc pathologies. The
changes in miRNA levels may be used as a diagnostic tool for
several types of cancer (Mitchell et al., 2008; Taylor and Gercel-
Taylor, 2008; Park et al., 2009; Hanke et al., 2010; Huang et al.,
2010; Zhao et al., 2010; Moussay et al., 2011; Roth et al., 2011),
cardiac damage (Ai et al., 2010; Corsten et al., 2010; Tijsen et al.,
2010; Wang et al., 2010a), muscular injury and pathologies (Lat-
erza et al., 2009; Mizuno et al., 2011; Vignier et al., 2013), diabetes
(Chen et al., 2008; Erener et al., 2013), liver injury (Laterza et al.,
2009; Wang et al., 2009, 2013; Starkey Lewis et al., 2011), among
others.
The literature reporting correlations with human disease and
pathologies has grown rapidly in the past few years. The number of
papers, for example, on changes in circulating miRNAs in cases of
myocardial infarction (MI) and cardiac diseases alone has recently
exploded. We estimate that more than 30 reports on this speciﬁc
topic alone have been published since 2009. Some of the circu-
lating miRNAs identiﬁed in MI and cardiac diseases have been
summarized in Table 1.
Efforts have also been made to use circulating miRNAs as a
prognostic tool in response to therapeutic treatments (Ma et al.,
2012). Furthermore, the possibility of using miRNAs as therapeu-
tics themselves has been considered. It is a very exciting prospect
if these molecules can be packaged and released into circulation
as stable and perhaps even targeted packages. Applications in this
area have taken different approaches. For example, creating syn-
thetic miRNAs designed to target speciﬁc disease-associated genes,
as used by Suckau et al. (2009) to treat heart failure. In this case,
viral vectors containing short hairpin RNAs were administered
intravenously in rats to reduce the level of a key regulator of car-
diac calcium homeostasis, phospholamban (Suckau et al., 2009).
The use of antagomirs to target miRNAs that are upregulated
in pathological states has also been demonstrated. For example,
an antagomir of miR-133 caused sustained cardiac hypertrophy
in mice (Care et al., 2007); antagomirs targeting miR-1 and let-
7f were successfully used in rats to extend neuroprotection after
ischemic stroke (Selvamani et al., 2012); mice treated with high
doses of an antagomir for miR-126 showed reduced ischemia-
induced angiogenesis (van Solingen et al., 2009); and a miR-206
antagomir increased brain-derived neurotrophic factor levels and
improved memory function in rats with Alzheimer’s disease (Lee
et al., 2012). Furthermore, a treatment for hepatitis C virus (HCV)
chronic infectionusing an antagomir for the liver-speciﬁcmiR-122
is currently in clinical trial (Janssen et al., 2013).
RNA EXPORT, PACKAGING, AND UPTAKE
While extracellular RNAs were ﬁrst thought to be molecular
debris released by cell lysis (Turchinovich et al., 2011), the dif-
ference in the spectrum of RNA within cultured cells and the
external medium argues strongly for selective export of some
fraction of the circulating RNAs (Wang et al., 2010b). It remains
unclear how speciﬁc RNAs are targeted for export, and if some
are simply released with the cytosol through bulk exocytosis.
As free RNA molecules are very likely to be degraded outside
the cell, it is generally assumed that circulating RNAs are pack-
aged in some form to avoid RNase degradation. Lipid vesicles,
such as exosomes or microvesicles are one type of packaging sys-
tem used by secreted RNAs (Valadi et al., 2007; Camussi et al.,
2011). Exosomes, which are approximately 30–100 nm in diame-
ter, are formed by fusion of multivesicular bodies with the plasma
membrane. Microvesicles are larger (100 nm–1 μm) and formed
by blebbing of the plasma membrane. Both types of vesicles
can contain a number of protein and RNA molecules, although
the composition varies widely with the origin of the vesicle
(Muller, 2012; Huang et al., 2013).
In addition to lipid vesicles, it has been demonstrated that
miRNA in the extracellular environment can complex with high-
density lipoproteins (HDL) and at least twoRNA-binding proteins
in vivo, Argonaute 1 (AGO1) and Argonaute 2 (AGO2), and with
nucleophosmin 1 (NPM1) in vitro (Wang et al., 2010b; Arroyo
et al., 2011; Turchinovich et al., 2011; Vickers et al., 2011; Turchi-
novich and Burwinkel, 2012; Wagner et al., 2013). Furthermore,
the spectrum of miRNA associated with HDL depends on the
health status of an individual (Vickers et al., 2011). However, it
is not known if there are other RNA-binding proteins that form
similar complexes to protect miRNAs or other types of RNA in
circulation.
Besides miRNAs, lipid vesicles also contain a large number of
protein-coding RNAs. Roughly 1300 different mRNA transcripts
have been identiﬁed in lipid vesicles derived fromhumanormouse
cell lines (Valadi et al., 2007). Interestingly, the mRNA composi-
tion and abundance in the exosomes differ from that of the original
cell, which suggests the contents in the lipid vesicles are selec-
tively packaged rather than included indiscriminately. The levels
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of circulating miRNAs as well as several mRNAs in circulation
have been shown to be associated with stages and types of cancers
(Sueoka et al., 2005; Mitchell et al., 2008; Taylor and Gercel-
Taylor, 2008; Ohshima et al., 2010; Zhao et al., 2010; Zhang et al.,
2012b), pregnancy (Zhong et al., 2008; Rajakumar et al., 2012;
Wu et al., 2012; Zhao et al., 2012; Higashijima et al., 2013), and
drug-induced liver injury (Miyamoto et al., 2008; Laterza et al.,
2009; Wang et al., 2009, 2013; Bala et al., 2012; Su et al., 2012;
Okubo et al., 2013).
The idea of using RNA as a mode of intercellular communi-
cation is particularly interesting for several reasons. First, RNA
can carry information in a simple and efﬁcient way (such as
coding for proteins in mRNA), and, second, it can coordinate
cellular activity in a fundamental and essential manner (such as
microRNA-mediated transcriptome and proteome regulation). It
has been demonstrated that cells can export miRNAs, which can
be transferred to and are functional in recipient cells (Kosaka
et al., 2010; Zhang et al., 2010; Hergenreider et al., 2012). How-
ever, it is inherently difﬁcult to test deﬁnitively the functioning
of an RNA-based communication system in vivo. Conditioned
media exchange and co-culture experiments have been used to
investigate cell–cell communications, and these methods have
been adapted to investigate the possibility of RNA uptake by
cells (Liu et al., 2010; Vencio et al., 2011; Yang et al., 2011). Some
exosome-derived mRNAs have been shown to be functional in
recipient cells (Valadi et al., 2007; Ismail et al., 2013). Further-
more, Ratajczak et al. (2006) showed that microvesicles derived
from embryonic stem cells can enhance the survival and expan-
sion of mouse hematopoietic progenitor cells, and are enriched in
stem cell related transcripts including Oct-4, Rex-1, Nanog, SCL,
and GATA-2. Reporter assays have shown that exosome-derived
miRNAs can silence transcripts in recipient cells (Lotvall and Val-
adi, 2007; Valadi et al., 2007; Camussi et al., 2011; Kogure et al.,
2011; Mittelbrunn et al., 2011). While evidence suggests that cul-
tured cells can transfer packaged RNA molecules, it is difﬁcult
to demonstrate this as a general mechanism in vivo. One of the
most important remaining biochemical questions is how the RNA
in circulation is protected, packaged, and delivered to and recog-
nized by their targets. The current lack of knowledge about these
questionsmakes the study of the biological functions of circulating
RNA both important and difﬁcult.
Besides protein-coding RNAs and miRNAs, there are other
more abundant types of regulatory RNA molecules, such as
large intergenic ncRNAs (lincRNAs) and small nucleolar RNAs
(snoRNAs) in extracellular vesicles (Huang et al., 2013). A recent
characterization of neuronal exosomes found RNAs derived from
repeat sequences, as well as mRNA and several types of small
RNAs. While a majority of small RNA was tRNA (90%), other
types of small RNAs including miRNA, snoRNA, and small cyto-
plasmic RNA (scRNA) were also detected (Bellingham et al.,
2012). Since both mRNA and miRNA can be taken up and
utilized by cells (see earlier paragraph), there is no reason
to think that other types of RNA in circulation do not also
have functional implications when they are taken up by cells.
However, there is currently no direct experimental evidence to
support this functional possibility for other types of RNA in
circulation.
METHODS USED IN STUDYING RNA IN CIRCULATION
Microarray, qPCR (quantitative polymerase chain reaction), and
sequencing-based approaches are the three major platforms that
have been used for miRNA and mRNA proﬁling. All of these
have been widely and successfully applied in assessing the spec-
tra of mRNA and miRNA in cells and tissues. However, due to
the relatively low concentration of RNA present in circulation,
comprehensive measurement of any circulating RNA is difﬁcult
to do accurately and consistently. For miRNAs, the difﬁculties
are compounded by the short lengths of the RNA molecules and
the consequent sequence speciﬁcity of hybridization free energies.
At the moment, the most commonly used method for miRNA
proﬁles is qPCR because of its sensitivity and the limited num-
ber of known miRNAs (on the order of 1000 sequences). This
method has signiﬁcant drawbacks as well because of the speciﬁcity
and differential ampliﬁcation efﬁciency of the designed primers.
This technique has also been applied to measure the level of spe-
ciﬁc mRNA sequences in circulation (Wang et al., 2013). Although
microarrays have been the gold standard for transcriptome analy-
sis in cells and tissues, the low concentration of RNA in circulation,
and the sequence similarity of these short nucleic acid molecules
make microarray analysis unsuitable in most cases. The develop-
ment of next generation sequencing (NGS) has shown promise in
measuring circulating RNAs. This platform not only solves some
of the miRNA measurement problems related to short and highly
similar sequences of miRNAs, but it can provide measurements
on a broad spectrum of RNA in a single experiment. Because it
does not rely on pre-designed probes or primers, NGS also allows
the identiﬁcation of novel RNA sequences, such as isomirs and
exogenous RNAs in circulation (Lee et al., 2010;Wang et al., 2010a,
2012; Semenov et al., 2012). One difﬁculty with this method is the
inherent bias in the preparation of the sequencing libraries. For
this reason, absolute measurements of circulating RNA are very
difﬁcult, but when carefully done, comparative measurements can
be reliable.
EXOGENOUS RNA IN CIRCULATION
Recent evidence, which we discuss below, suggests that RNAs in
circulation are derived not only from cells within the human body,
but also from foreign organisms and viruses (Meckes et al., 2010;
Pegtel et al., 2010). It has been shown that exogenous RNAs ﬁnd
their way from the outside environment, through diet or from the
complex human microbiome (Zhang et al., 2012a). Little is known
about how exogenous RNAs are taken up by the gut epithelium
from the environment, and there is only very limited and circum-
stantial evidence so far that these RNAs are functional in the body.
However, in keeping with the substantial and growing body of
evidence that some human circulating RNA are functional, the
possibility that exogenous RNAs, found in the circulation can be
takenupandexert speciﬁc functions in recipient cells, raises several
interesting issues.
A recent report byZhang et al. (2012a) indicated that exogenous
miRNAs ingested from food (rice in this case) could enter into the
human circulation and be taken up by and actually function in
cells. They found that certain plant miRNAs, including miR-168a,
an abundant miRNA in rice, is detectable in human plasma, as
well as in plasma from other animals eating a diet containing plant
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material. However, many questions such as how the RNA survives
the cooking process and the harsh environment of the digestive
tract, as well as how these biomolecules can pass through the gut
epithelium, remain largely unanswered. Using Caco-2 cells trans-
fected with synthetic rice miR-168a, Zhang et al. (2012a) found
that transfected miR-168a can be packaged by cells into microvesi-
cles and released into culture medium. Furthermore, their work
suggests that the microvesicles containing exogenous miRNA can
be taken up by cells and interact with endogenous transcripts both
in vitro and in vivo. Mature miR-168a sequence has signiﬁcant
sequence homology with a liver-expressed transcript, low-density
lipoprotein receptor adaptor protein 1 (LDLRAP1) transcript,
raising the possibility that it can suppress the expression of LDL-
RAP1 through the action of the RISC complex. Indeed, mice fed
a rice-containing diet have lower level of LDLRAP1 gene expres-
sion than mice fed a normal chow diet, suggesting that miR-168a
derived from the rice can affect the level of an endogenous mouse
transcript (Zhang et al., 2012a).
Recent work by our lab and others have systematically charac-
terized the composition of RNAs in circulation and revealed that
some of the circulating RNAs are derived from a variety of exoge-
nous organisms, including the microbiome (Semenov et al., 2012;
Wang et al., 2012, 2013). Using a map-and-remove strategy to ana-
lyze small RNA-seq data (after removing sequences mapped to
human miRNAs, transcripts, and genomic sequences ﬁrst), reveals
that a signiﬁcant portion of the total reads are of non-human ori-
gin. While some of these exogenous RNAs are derived from the
diet, the majority of them are of either fungal or bacterial ori-
gins (Wang et al., 2012). The sequences detected implicate a wide
range of bacterial phyla, including many already known to reside
in the gut microbiome. Although there were not signiﬁcant differ-
ences in the plasma RNA spectra between healthy individuals and
those with colorectal cancer or ulcerative colitis, differences can be
detected in the plasma of people eating different diets, such as a
corn-based diet versus a rice-based diet (Wang et al., 2012).
While these results raise the interesting possibility that exoge-
nous RNAs taken up from the environment can alter gene
expression in the cells of an organism, many questions remain
unanswered. How these RNAs pass through the body’s epithelial
lining barrier and enter the circulation, for example, is still com-
pletely unclear. Because of the relatively low levels of exogenous
circulating RNA, it seems likely that if the packages containing
exogenous RNAs exert a signiﬁcant biological effect on the body’s
cells they must be effectively targeted in some way to speciﬁc cells
or tissues.
Since some miRNAs are highly conserved in metazoans (Shi
et al., 2012), the ﬁnding of diet derived exogenous RNA in circu-
lation raises the interesting possibility that there are RNA-based
processes that either induce or avert the development of diseases
in humans arising from foreign RNA. For example, changing the
levels of certain highly conserved miRNAs, such as miR-21, which
has solid pro-proliferation activity (Sayed et al., 2008; Yao et al.,
2009), and miR-150 and miR-146, which have strong association
with inﬂammation activities (Sheedy and O’Neill, 2008; Sonkoly
et al., 2008; Schmidt et al., 2009; Quinn and O’Neill, 2011; Zhong
et al., 2012), by uptake of exogenous RNAs with similar activities
may affect the initiation and progression of certain diseases.
Although promising both as biomarkers and potential func-
tional impacts, such as for therapeutics, there is still a great deal to
be learned about RNA in circulation. This newly recognized class
of circulating molecules has the potential to be deeply involved in
the symbiotic functioning of the human body and its microbiome.
We currently know very little about the potential mechanisms of
entry of RNAs into circulation, their mechanisms of action, their
packaging and export process, and their targeting and uptake by
cells. Technical improvements and standardization in measur-
ing the levels of these RNAs as well as new model experimental
systems are needed in order to explore the many facets of the
transport, targeting, and function of these RNAs. In summary,
the health impact of RNAs in circulation seems likely to be sig-
niﬁcant, but the ﬁeld is just beginning to be explored and the
investigation of the area of the quantitative characterization and
speciﬁc biological functions of exogenous RNA is even earlier in its
development.
REFERENCES
Adachi, T., Nakanishi, M., Otsuka, Y.,
Nishimura, K., Hirokawa, G., Goto,
Y., et al. (2010). Plasma microRNA
499 as a biomarker of acute myocar-
dial infarction. Clin. Chem. 56, 1183–
1185. doi: 10.1373/clinchem.2010.
144121
Ai, J., Zhang, R., Li, Y., Pu, J.,
Lu, Y., Jiao, J., et al. (2010). Cir-
culating microRNA-1 as a potential
novel biomarker for acute myocar-
dial infarction. Biochem. Biophys.
Res. Commun. 391, 73–77. doi:
10.1016/j.bbrc.2009.11.005
Arroyo, J. D., Chevillet, J. R., Kroh, E.
M., Ruf, I. K., Pritchard, C. C., Gib-
son, D. F., et al. (2011). Argonaute2
complexes carry a population of cir-
culating microRNAs independent of
vesicles in human plasma. Proc. Natl.
Acad. Sci. U.S.A. 108, 5003–5008. doi:
10.1073/pnas.1019055108
Bala, S., Petrasek, J., Mundkur, S., Cata-
lano, D., Levin, I., Ward, J., et al.
(2012). Circulating microRNAs in
exosomes indicate hepatocyte injury
and inﬂammation in alcoholic, drug-
induced, and inﬂammatory liver dis-
eases. Hepatology 56, 1946–57. doi:
10.1002/hep.25873
Bellingham, S. A., Coleman, B. M., and
Hill, A. F. (2012). Small RNA deep
sequencing reveals a distinct miRNA
signature released in exosomes from
prion-infected neuronal cells. Nucleic
Acids Res. 40, 10937–10949. doi:
10.1093/nar/gks832
Camussi, G., Deregibus, M. C., Bruno,
S., Grange, C., Fonsato, V., and Tetta,
C. (2011).Exosome/microvesicle-
mediated epigenetic reprogramming
of cells. Am. J. Cancer Res. 1, 98–110.
doi: 10.1093/hmg/dds317
Care, A., Catalucci, D., Felicetti, F.,
Bonci, D., Addario, A., Gallo, P.,
et al. (2007). MicroRNA-133 controls
cardiac hypertrophy. Nat. Med. 13,
613–618. doi: 10.1038/nm1582
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y.,
Wang, K., et al. (2008). Characteriza-
tion of microRNAs in serum: a novel
class of biomarkers for diagnosis of
cancer andother diseases.Cell Res. 18,
997–1006. doi: 10.1038/cr.2008.282
Chendrimada, T. P., Finn, K. J., Ji,
X., Baillat, D., Gregory, R. I., Lieb-
haber, S. A., et al. (2007). MicroRNA
silencing through RISC recruitment
of eIF6. Nature 447, 823–828. doi:
10.1038/nature05841
Cheng, Y., Tan, N., Yang, J., Liu, X.,
Cao, X., He, P., et al. (2010). A
translational study of circulating cell-
free microRNA-1 in acute myocardial
infarction. Clin. Sci. (Lond.) 119,
87–95. doi: 10.1042/CS20090645
Chillakuri, C. R., Sheppard, D.,
Lea, S. M., and Handford, P. A.
(2012). Notch receptor–ligand bind-
ing and activation: insights from
molecular studies. Semin. Cell Dev.
Biol. 23, 421–428. doi: 10.1016/
j.semcdb.2012.01.009
Chim, S. S., Shing, T. K., Hung,
E. C., Leung, T. Y., Lau, T. K.,
Chiu, R. W., et al. (2008). Detec-
tion and characterization of placen-
tal microRNAs in maternal plasma.
Clin. Chem. 54, 482–90. doi:
10.1373/clinchem.2007.097972
Corsten, M. F., Dennert, R., Jochems,
S., Kuznetsova, T., Devaux, Y., Hof-
stra, L., et al. (2010). Circulating
microRNA-208b and microRNA-
499 reﬂect myocardial damage
in cardiovascular disease. Circ.
Cardiovasc. Genet. 3, 499–506.
doi: 10.1161/CIRCGENETICS.110.
957415
Cortez, M. A., Bueso-ramos, C., Fer-
din, J., Lopez-berestein, G., Sood,
www.frontiersin.org June 2013 | Volume 4 | Article 115 | 5
“fgene-04-00115” — 2013/6/15 — 15:49 — page 6 — #6
Etheridge et al. Circulating RNA
A. K., and Calin, G. A. (2011).
MicroRNAs in body ﬂuids – the mix
of hormones and biomarkers. Nat.
Rev. Clin. Oncol. 8, 467–477. doi:
10.1038/nrclinonc.2011.76
D’Alessandra, Y., Devanna, P., Limana,
F., Straino, S., Di carlo, A., Bram-
billa, P. G., et al. (2010). Circulating
microRNAs are new and sensitive
biomarkers of myocardial infarction.
Eur. Heart J. 31, 2765–2773. doi:
10.1093/eurheartj/ehq221
Devaux, Y., Vausort, M., Goretti,
E., Nazarov, P. V., Azuaje, F.,
Gilson, G., et al. (2012). Use of
circulating microRNAs to diagnose
acute myocardial infarction. Clin.
Chem. 58, 559–567. doi: 10.1373/
clinchem.2011.173823
Erener, S., Mojibian, M., Fox, J. K., Den-
roche, H. C., and Kieffer, T. J. (2013).
Circulating miR-375 as a biomarker
of beta-cell death and diabetes in
mice. Endocrinology 154, 603–608.
doi: 10.1210/en.2012-1744
Fabian, M. R., Sonenberg, N., and Fil-
ipowicz, W. (2010). Regulation of
mRNA translation and stability by
microRNAs. Annu. Rev. Biochem.
79, 351–379. doi: 10.1146/annurev-
biochem-060308-103103
Filipowicz, W., Bhattacharyya, S. N.,
and Sonenberg, N. (2008). Mecha-
nisms of post-transcriptional regula-
tion by microRNAs: are the answers
in sight? Nat. Rev. Genet. 9, 102–114.
doi: 10.1038/nrg2290
Gerdes, H. H., and Carvalho, R. N.
(2008). Intercellular transfer medi-
ated by tunneling nanotubes. Curr.
Opin. Cell Biol. 20, 470–475. doi:
10.1016/j.ceb.2008.03.005
Hanke, M., Hoeﬁg, K., Merz, H.,
Feller, A. C., Kausch, I., Jocham,
D., et al. (2010). A robust method-
ology to study urine microRNA as
tumor marker: microRNA-126 and
microRNA-182 are related to uri-
nary bladder cancer. Urol. Oncol.
28, 655–661. doi: 10.1016/j.urolonc.
2009.01.027
Hergenreider, E., Heydt, S., Treguer, K.,
Boettger, T., Horrevoets, A. J., Zeiher,
A. M., et al. (2012). Atheroprotective
communication between endothelial
cells and smoothmuscle cells through
miRNAs. Nat. Cell Biol. 14, 249–256.
doi: 10.1038/ncb2441
Higashijima, A., Miura, K., Mishima,
H., Kinoshita, A., Jo, O., Abe, S., et al.
(2013). Characterization of placenta-
speciﬁc microRNAs in fetal growth
restriction pregnancy. Prenat. Diagn.
33, 214–222. doi: 10.1002/pd.4045
Huang, X., Yuan, T., Tschannen, M.,
Sun, Z., Jacob, H., Du, M., et al.
(2013). Characterization of human
plasma-derived exosomal RNAs by
deep sequencing. BMC Genomics
14:319. doi: 10.1186/1471-2164-
14-319
Huang, Z., Huang, D., Ni, S., Peng,
Z., Sheng, W., and Du, X. (2010).
Plasma microRNAs are promising
novel biomarkers for early detection
of colorectal cancer. Int. J. Can-
cer 127, 118–126. doi: 10.1002/ijc.
25007
Hunter, M. P., Ismail, N., Zhang,
X., Aguda, B. D., Lee, E. J.,
Yu, L., et al. (2008). Detection
of microRNA expression in human
peripheral blood microvesicles. PLoS
ONE 3:e3694. doi: 10.1371/journal.
pone.0003694
Ismail, N., Wang, Y., Dakhlallah, D.,
Moldovan, L., Agarwal, K., Batte, K.,
et al. (2013). Macrophage microvesi-
cles induce macrophage differentia-
tion and miR-223 transfer. Blood 121,
984–995. doi: 10.1182/blood-2011-
08-374793
Janssen, H. L., Reesink, H. W., Lawitz,
E. J., Zeuzem, S., Rodriguez-Torres,
M., Patel, K., et al. (2013). Treat-
ment of HCV infection by target-
ing microRNA. N. Engl. J. Med.
368, 1685–1694. doi: 10.1056/NEJ-
Moa1209026
Kogure, T., Lin,W. L.,Yan, I. K., Braconi,
C., and Patel, T. (2011). Intercellu-
lar nanovesicle-mediated microRNA
transfer: a mechanism of environ-
mental modulation of hepatocellu-
lar cancer cell growth. Hepatology
54, 1237–1248. doi: 10.1002/hep.
24504
Kohler, C., Barekati, Z., Radpour, R.,
and Zhong, X. Y. (2011). Cell-free
DNA in the circulation as a potential
cancer biomarker. Anticancer Res. 31,
2623–2628. doi: 10.1186/1476-4598-
8-105
Kosaka, N., Iguchi, H., Yoshioka,
Y., Takeshita, F., Matsuki, Y., and
Ochiya, T. (2010). Secretory mech-
anisms and intercellular transfer of
microRNAs in living cells. J. Biol.
Chem. 285, 17442–17452. doi:
10.1074/jbc.M110.107821
Kuwabara, Y., Ono, K., Horie, T.,
Nishi, H., Nagao, K., Kinoshita, M.,
et al. (2011). Increased microRNA-
1 and microRNA-133a levels in
serum of patients with cardiovascu-
lar disease indicate myocardial dam-
age. Circ. Cardiovasc. Genet. 4,
446–454. doi: 10.1161/CIRCGENET-
ICS.110.958975
Laterza, O. F., Lim, L., Garrett-Engele,
P. W., Vlasakova, K., Muniappa,
N., Tanaka, W. K., et al. (2009).
Plasma microRNAs as sensitive and
speciﬁc biomarkers of tissue injury.
Clin. Chem. 55, 1977–1983. doi:
10.1373/clinchem.2009.131797
Lawrie, C. H., Gal, S., Dunlop, H. M.,
Pushkaran, B., Liggins, A. P., Pul-
ford, K., et al. (2008). Detection of
elevated levels of tumor-associated
microRNAs in serum of patients with
diffuse large B-cell lymphoma. Br.
J. Haematol. 141, 672–675. doi:
10.1111/j.1365-2141.2008.07077.x
Lee, L. W., Zhang, S., Etheridge, A., Ma,
L., Martin, D., Galas, D., et al. (2010).
Complexity of the microRNA reper-
toire revealed by next-generation
sequencing. RNA 16, 2170–2180. doi:
10.1261/rna.2225110
Lee, S. T., Chu, K., Jung, K. H.,
Kim, J. H., Huh, J. Y., Yoon,
H., et al. (2012). miR-206 regu-
lates brain-derived neurotrophic fac-
tor in Alzheimer disease model. Ann.
Neurol. 72, 269–277. doi: 10.1002/
ana.23588
Lim, P. K., Bliss, S. A., Patel, S. A.,
Taborga, M., Dave, M. A., Gregory,
L. A., et al. (2011). Gap junction-
mediated import of microRNA from
bone marrow stromal cells can elicit
cell cycle quiescence in breast cancer
cells. Cancer Res. 71, 1550–1560. doi:
10.1158/0008-5472.CAN-10-2372
Liu, A. Y., Pascal, L. E., Vencio, R. Z.,
and Vencio, E. F. (2010). Stromal–
epithelial interactions in early neo-
plasia. Cancer Biomarker 9, 141–155.
doi: 10.3233/CBM-2011-0174
Lo, Y. M., and Chiu, R. W. (2012).
Genomic analysis of fetal nucleic
acids in maternal blood. Annu. Rev.
Genomics Hum. Genet. 13, 285–
306. doi: 10.1146/annurev-genom-
090711-163806
Lotvall, J., and Valadi, H. (2007). Cell to
cell signalling via exosomes through
esRNA. Cell Adh. Migr. 1, 156–158.
doi: 10.4161/cam.1.3.5114
Ma, Y., Zhang, P., Wang, F., Zhang, H.,
Yang, J., Peng, J., et al. (2012). miR-
150 as a potential biomarker associ-
ated with prognosis and therapeutic
outcome in colorectal cancer. Gut
61, 1447–1453. doi: 10.1136/gutjnl-
2011-301122
Mandel, P., and Métais, P. (1948).
Les acides nucléiques du plasma san-
guin chez l’homme. C. R. Acad. Sci.
Paris 142, 241–243. doi: 10.1373/
clinchem.2005.051003
Meckes, D. G. Jr., Shair, K. H.
Y., Marquitz, A. R., Kung, C.
P., Edwards, R. H., and Raab-
Traub, N. (2010). Human tumor
virus utilizes exosomes for intercellu-
lar communication. Proc. Natl. Acad.
Sci. U.S.A. 107, 20370–20375. doi:
10.1073/pnas.1014194107
Meder, B., Keller, A., Vogel, B., Haas,
J., Sedaghat-Hamedani, F., Kayvan-
pour, E., et al. (2011). MicroRNA
signatures in total peripheral blood as
novel biomarkers for acute myocar-
dial infarction. Basic Res. Cardiol.
106, 13–23. doi: 10.1007/s00395-010-
0123-2
Mitchell, P. S., Parkin, R. K., Kroh,
E. M., Fritz, B. R., Wyman, S. K.,
Pogosova-Agadjanyan, E. L., et al.
(2008). Circulating microRNAs as
stable blood-based markers for can-
cer detection. Proc. Natl. Acad.
Sci. U.S.A. 105, 10513–10518. doi:
10.1073/pnas.0804549105
Mittelbrunn, M., Gutierrez-Vazquez,
C., Villarroya-Celtri, C., Gonzalez,
S., Sanchez-Cabo, F., Gonzalez, M.
A., et al. (2011). Unidirectional trans-
fer of microRNA-loaded exosomes
from T cells to antigen-presenting
cells. Nat. Commun. 2, 282. doi:
10.1038/ncomms1285
Miyamoto, M., Yanai, M., Ookubo, S.,
Awasaki, N., Takami, K., and Imai,
R. (2008). Detection of cell-free,
liver-speciﬁc mRNAs in peripheral
blood from rats with hepatotoxicity:
a potential toxicological biomarker
for safety evaluation. Toxicol. Sci.
106, 538–545. doi: 10.1093/toxsci/
kfn188
Mizuno, H., Nakamura, A., Aoki, Y.,
Ito, N., Kishi, S., Yamamoto, K., et al.
(2011). Identiﬁcation of muscle-
speciﬁc microRNAs in serum of
muscular dystrophy animal models:
promising novel blood-based mark-
ers for muscular dystrophy. PLoS
ONE 6:e18388. doi: 10.1371/jour-
nal.pone.0018388
Montecalvo, A., Larregina, A. T.,
Shufesky, W. J., Stolz, D. B., Sullivan,
M. L., Karlsson, J. M., et al. (2012).
Mechanism of transfer of functional
microRNAsbetweenmousedendritic
cells via exosomes. Blood 119, 756–
766. doi: 10.1182/blood-2011-02-
338004
Moussay, E., Wang, K., Cho, J. H., van
Moer, K., Pierson, S., Paggetti, J.,
et al. (2011). MicroRNA as biomark-
ers and regulators in B-cell chronic
lymphocytic leukemia. Proc. Natl.
Acad. Sci. U.S.A. 108, 6573–6578. doi:
10.1073/pnas.1019557108
Muller, G. (2012). Microvesicles/
exosomes as potential novel biomark-
ers of metabolic diseases. Diabetes
Metab. Syndr. Obes. 5, 247–282. doi:
10.2147/DMSO.S32923
Ohshima, K., Inoue, K., Fujiwara, A.,
Hatakeyama, K., Kanto, K., Watan-
abe, Y., et al. (2010). Let-7 microRNA
family is selectively secreted into the
extracellular environment via exo-
somes in a metastatic gastric cancer
cell line. PLoS ONE 5:e13247. doi:
10.1371/journal.pone.0013247
Okubo, S., Miyamoto, M., Takami,
K., Kanki, M., Ono, A., Nakatsu,
Frontiers in Genetics | Non-Coding RNA June 2013 | Volume 4 | Article 115 | 6
“fgene-04-00115” — 2013/6/15 — 15:49 — page 7 — #7
Etheridge et al. Circulating RNA
N., et al. (2013). Identiﬁcation of
novel liver-speciﬁc mRNAs in plasma
for biomarkers of drug-induced liver
injury and quantitative evaluation in
rats treated with various hepatotoxic
compounds. Toxicol. Sci. 132, 21–31.
doi: 10.1093/toxsci/kfs340
Park, N. J., Zhou, H., Elashoff, D.,
Henson, B. S., Kastratovic, D. A.,
Abemayor, E., et al. (2009). Sali-
varymicroRNA:discovery, character-
ization, and clinical utility for oral
cancer detection. Clin. Cancer Res.
15, 5473–5477. doi: 10.1158/1078-
0432.CCR-09-0736
Pegtel, D. M., Cosmopoulos, K.,
Thorley-Lawson, D. A., van Eijnd-
hoven, M. A., Hopmans, E. S., Lin-
denberg, J. L., et al. (2010). Func-
tional delivery of viral miRNAs via
exosomes. Proc. Natl. Acad. Sci.
U.S.A. 107, 6328–6333. doi: 10.1073/
pnas.0914843107
Quinn, S. R., and O’Neill, L. A.
(2011). A trio of microRNAs that
control toll-like receptor signaling.
Int. Immunol. 23, 421–425. doi:
10.1093/intimm/dxr034
Rajakumar, A., Cerdeira, A. S., Rana,
S., Zsengeller, Z., Edmunds, L.,
Jeyabalan, A., et al. (2012). Tran-
scriptionally active syncytial aggre-
gates in the maternal circulation
may contribute to circulating sol-
uble fms-like tyrosine kinase 1 in
preeclampsia. Hypertension 59, 256–
264. doi: 10.1161/HYPERTENSION-
AHA.111.182170
Ratajczak, J., Miekus, K., Kucia, M.,
Zhang, J., Reca, R., Dvorak, P., et al.
(2006). Embryonic stem cell-derived
microvesicles reprogram hematopoi-
etic progenitors: evidence for hori-
zontal transfer of mRNA and protein
delivery. Leukemia 20, 847–856. doi:
10.1038/sj.leu.2404132
Roth, P., Wischhusen, J., Happold, C.,
Chandran, P. A., Hofer, S., Eisele,
G., et al. (2011). A speciﬁc miRNA
signature in the peripheral blood of
glioblastoma patients. J. Neurochem.
118, 449–457. doi: 10.1111/j.1471-
4159.2011.07307.x
Sayed, D., Rane, S., Lypowy, J., He,
M., Chen, I. Y., Vashistha, H.,
et al. (2008). MicroRNA-21 targets
Sprouty2 and promotes cellular out-
growths. Mol. Biol. Cell 19, 3272–
3282. doi: 10.1091/mbc.E08-02-0159
Schmidt, W. M., Spiel, A. O., Jilma, B.,
Wolzt, M., and Muller, M. (2009).
In vivo proﬁle of the human leuko-
cyte microRNA response to endotox-
emia. Biochem. Biophys. Res. Com-
mun. 380, 437–441. doi: 10.1016/
j.bbrc.2008.12.190
Schonbeck,U., and Libby, P. (2001). The
CD40/CD154 receptor/ligand dyad.
Cell. Mol. Life Sci. 58, 4–43. doi:
10.1007/PL00000776
Selvamani, A., Sathyan, P., Miranda,
R. C., and Sohrabji, F. (2012).
An antagomir to microRNA Let7f
promotes neuroprotection in an
ischemic stroke model. PLoS ONE
7:e32662. doi: 10.1371/journal.pone.
0032662
Semenov, D. V., Baryakin, D. N.,
Brenner, E. V., Kurilshikov, A. M.,
Vasiliev, G. V., Bryzgalov, L. A., et al.
(2012). Unbiased approach to pro-
ﬁle the variety of small non-coding
RNA of human blood plasma with
massively parallel sequencing tech-
nology. Expert Opin. Biol. Ther.
12(Suppl. 1), S43–S51. doi: 10.1517/
14712598.2012.679653
Sheedy, F. J., and O’Neill, L. A.
(2008). Adding fuel to ﬁre: microR-
NAs as a new class of media-
tors of inﬂammation. Ann. Rheum.
Dis. 67(Suppl. 3), iii50–iii55. doi:
10.1136/ard.2008.100289
Shi, B., Gao, W., and Wang, J.
(2012). Sequence ﬁngerprints of
microRNA conservation. PLoS ONE
7:e48256. doi: 10.1371/journal.pone.
0048256
Skog, J., Wurdinger, T., van Rijn,
S., Meijer, D. H., Gainche, L.,
Sena-Esteves, M., et al. (2008).
Glioblastomamicrovesicles transport
RNA and proteins that promote
tumour growth and provide diagnos-
tic biomarkers. Nat. Cell Biol. 10,
1470–1476. doi: 10.1038/ncb1800
Sonkoly, E., Stahle, M., and Pivarcsi, A.
(2008). MicroRNAs and immunity:
novel players in the regulation of nor-
mal immune function and inﬂam-
mation. Semin. Cancer Biol. 18,
131–140. doi: 10.1016/j.semcancer.
2008.01.005
Starkey Lewis, P. J., Dear, J., Platt,
V., Simpson, K. J., Craig, D. G.,
Antoine, D. J., et al. (2011). Circu-
lating microRNAs as potential mark-
ers of human drug-induced liver
injury. Hepatology 54, 1767–1776.
doi: 10.1002/hep.24538
Su, Y. W., Chen, X., Jiang, Z. Z.,
Wang, T., Wang, C., Zhang, Y., et al.
(2012). A panel of serum microRNAs
as speciﬁc biomarkers for diagnosis of
compound- and herb-induced liver
injury in rats. PLoS ONE 7:e37395.
doi: 10.1371/journal.pone.0037395
Suckau, L., Fechner, H., Chemaly, E.,
Krohn, S., Hadri, L., Kockskamper,
J., et al. (2009). Long-term cardiac-
targeted RNA interference for the
treatment of heart failure restores
cardiac function and reduces patho-
logical hypertrophy. Circulation 119,
1241–1252. doi: 10.1161/CIRCULA-
TIONAHA.108.783852
Sueoka, E., Sueoka, N., Iwanaga, K.,
Sato, A., Suga, K., Hayashi, S., et al.
(2005). Detection of plasma hnRNP
B1 mRNA, a new cancer biomarker,
in lung cancer patients by quantita-
tive real-time polymerase chain reac-
tion. Lung Cancer 48, 77–83. doi:
10.1016/j.lungcan.2004.10.007
Taylor, D. D., and Gercel-Taylor, C.
(2008). MicroRNA signatures of
tumor-derived exosomes as diagnos-
tic biomarkers of ovarian cancer.
Gynecol. Oncol. 110, 13–21. doi:
10.1016/j.ygyno.2008.04.033
Tijsen, A. J., Creemers, E. E., Moer-
land, P. D., de Windt, L. J., van
der Wal, A. C., Kok, W. E., et al.
(2010). MiR423-5p as a circulating
biomarker for heart failure. Circ. Res.
106, 1035–1039. doi: 10.1161/CIR-
CRESAHA.110.218297
Turchinovich, A., and Burwinkel, B.
(2012). Distinct AGO1 and AGO2
associated miRNA proﬁles in human
cells and blood plasma. RNA Biol. 9,
1066–1075. doi: 10.4161/rna.21083
Turchinovich, A., Weiz, L., Langheinz,
A., and Burwinkel, B. (2011). Char-
acterization of extracellular circulat-
ing microRNA. Nucleic Acids Res. 39,
7223–7233. doi: 10.1093/nar/gkr254
Valadi, H., Ekstrom, K., Bossios, A.,
Sjostrand, M., Lee, J. J., and Lot-
vall, J. O. (2007). Exosome-mediated
transfer of mRNAs and microRNAs
is a novel mechanism of genetic
exchange between cells. Nat. Cell
Biol. 9, 654–659. doi: 10.1038/
ncb1596
Valiunas, V., Polosina, Y. Y., Miller,
H., Potapova, I. A., Valiuniene,
L., Doronin, S., et al. (2005).
Connexin-speciﬁc cell-to-cell trans-
fer of short interfering RNA by gap
junctions. J. Physiol. 568, 459–468.
doi: 10.1113/jphysiol.2005.090985
van Solingen, C., Seghers, L., Bijk-
erk, R., Duijs, J. M., Roeten, M.
K., van Oeveren-Rietdijk, A. M.,
et al. (2009). Antagomir-mediated
silencing of endothelial cell speciﬁc
microRNA-126 impairs ischemia-
induced angiogenesis. J. Cell. Mol.
Med. 13, 1577–1585. doi: 10.1111/
j.1582-4934.2008.00613.x
Vencio, E. F., Pascal, L. E., Page, L. S.,
Denyer, G., Wang, A. J., Ruohola-
Baker, H., et al. (2011). Embryonal
carcinoma cell induction of miRNA
and mRNA changes in co-cultured
prostate stromal ﬁbromuscular cells.
J. Cell. Physiol. 226, 1479–1488. doi:
10.1002/jcp.22464
Vickers, K. C., Palmisano, B. T., Shou-
cri, B. M., Shamburek, R. D., and
Remaley, A. T. (2011). MicroRNAs
are transported in plasma and deliv-
ered to recipient cells by high-density
lipoproteins. Nat. Cell Biol. 13, 423–
433. doi: 10.1038/ncb2210
Vignier, N., Amor, F., Fogel, P.,
Duvallet, A., Poupiot, J., Charrier,
S., et al. (2013). Distinctive serum
miRNA proﬁle in mouse models of
striated muscular pathologies. PLoS
ONE 8:e55281. doi: 10.1371/jour-
nal.pone.0055281
Wagner, J., Riwanto, M., Besler, C.,
Knau, A., Fichtlscherer, S., Roxe,
T., et al. (2013). Characterization of
levels and cellular transfer of cir-
culating lipoprotein-bound microR-
NAs. Arterioscler. Thromb. Vasc.
Biol. 33, 1392–1400. doi: 10.1161/
ATVBAHA.112.300741
Wang, G. K., Zhu, J. Q., Zhang, J.
T., Li, Q., Li, Y., He, J., et al.
(2010a). Circulating microRNA: a
novel potential biomarker for early
diagnosis of acute myocardial infarc-
tion in humans. Eur. Heart J.
31, 659–666. doi: 10.1093/eurheartj/
ehq013
Wang, K., Zhang, S., Weber, J., Baxter,
D., and Galas, D. J. (2010b). Export
of microRNAs and microRNA-
protective protein by mammalian
cells. Nucleic Acids Res. 38, 7248–
7259. doi: 10.1093/nar/gkq601
Wang, K., Li, H., Yuan, Y., Etheridge,
A., Zhou, Y., Huang, D., et al.
(2012). The complex exogenous RNA
spectra in human plasma: an inter-
face with human gut biota? PLoS
ONE 7:e51009. doi: 10.1371/journal.
pone.0051009
Wang, K., Yuan, Y., Li, H., Cho,
J. H., Huang, D., Gray, L., et al.
(2013). The spectrum of circulating
RNA, a window into systems toxicol-
ogy. Toxicol. Sci. 132, 478–492. doi:
10.1093/toxsci/kft014
Wang, K., Zhang, S., Marzolf, B.,
Troisch, P., Brightman, A., Hu, Z.,
et al. (2009). Circulating microR-
NAs, potential biomarkers for drug-
induced liver injury. Proc. Natl. Acad.
Sci. U.S.A. 106, 4402–4407. doi:
10.1073/pnas.0813371106
Wang, R., Li, N., Zhang, Y., Ran,
Y., and Pu, J. (2011). Circu-
lating microRNAs are promising
novel biomarkers of acutemyocardial
infarction. Intern. Med. 50, 1789–
1795. doi: 10.2169/internalmedicine.
50.5129
Weber, J. A., Baxter, D. H., Zhang,
S., Huang, D. Y., Huang, K. H.,
Lee, M. J., et al. (2010). The
microRNA spectrum in 12 body ﬂu-
ids. Clin. Chem. 56, 1733–1741. doi:
10.1373/clinchem.2010.147405
Wolvetang, E. J., Pera, M. F.,
and Zuckerman, K. S. (2007).
Gap junction mediated transport of
shRNA between human embryonic
www.frontiersin.org June 2013 | Volume 4 | Article 115 | 7
“fgene-04-00115” — 2013/6/15 — 15:49 — page 8 — #8
Etheridge et al. Circulating RNA
stem cells. Biochem. Biophys. Res.
Commun. 363, 610–615. doi:
10.1016/j.bbrc.2007.09.035
Wu, L., Zhou, H., Lin, H., Qi, J., Zhu,
C., Gao, Z., et al. (2012). Circulating
microRNAs are elevated in plasma
from severe preeclamptic pregnan-
cies. Reproduction 143, 389–397. doi:
10.1530/REP-11-0304
Yang, M., Chen, J., Su, F., Yu, B., Lin,
L., Liu, Y., et al. (2011). Microvesi-
cles secreted by macrophages shut-
tle invasion-potentiating microRNAs
into breast cancer cells. Mol. Cancer
10, 117. doi: 10.1186/1476-4598-10-
117
Yao, Q., Xu, H., Zhang, Q. Q., Zhou,
H., and Qu, L. H. (2009). MicroRNA-
21 promotes cell proliferation and
down-regulates the expression of
programmed cell death 4 (PDCD4)
in HeLa cervical carcinoma cells.
Biochem. Biophys. Res. Commun. 388,
539–542. doi: 10.1016/j.bbrc.2009.
08.044
Zhang, L., Hou, D., Chen, X., Li, D.,
Zhu, L., Zhang, Y., et al. (2012a).
Exogenous plant MIR168a speciﬁ-
cally targets mammalian LDLRAP1:
evidence of cross-kingdom regula-
tion by microRNA. Cell Res. 22,
107–126. doi: 10.1038/cr.2011.158
Zhang, X., Wang, C., Wang, L., Du,
L., Wang, S., Zheng, G., et al.
(2012b). Detection of circulating
Bmi-1 mRNA in plasma and its
potential diagnostic and prognos-
tic value for uterine cervical cancer.
Int. J. Cancer 131, 165–172. doi:
10.1002/ijc.26360
Zhang, Y., Liu, D., Chen, X.,
Li, J., Li, L., Bian, Z., et al.
(2010). Secreted monocytic miR-
150 enhances targeted endothelial cell
migration.Mol. Cell 39, 133–144. doi:
10.1016/j.molcel.2010.06.010
Zhao, H., Shen, J., Medico, L., Wang,
D., Ambrosone, C. B., and Liu, S.
(2010). A pilot study of circulating
miRNAs as potential biomarkers of
early stage breast cancer. PLoS ONE
5:e13735. doi: 10.1371/journal.pone.
0013735
Zhao, Z., Zhao, Q., Warrick, J.,
Lockwood, C. M., Woodworth, A.,
Moley, K. H., et al. (2012). Cir-
culating microRNA miR-323-3p as
a biomarker of ectopic pregnancy.
Clin. Chem. 58, 896–905. doi:
10.1373/clinchem.2011.179283
Zhong, S., Zhang, S., Bair, E., Nares,
S., and Khan, A. A. (2012). Dif-
ferential expression of microRNAs
in normal and inﬂamed human
pulps. J. Endod. 38, 746–752. doi:
10.1016/j.joen.2012.02.020
Zhong, X.Y., Holzgreve,W., and Huang,
D. J. (2008). Isolation of cell-free
RNA from maternal plasma. Meth-
ods Mol. Biol. 444, 269–273. doi:
10.1007/978-1-59745-066-9_21
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 18April 2013; accepted: 31May
2013; published online: 18 June 2013.
Citation: Etheridge A, Gomes CPC,
Pereira RW, Galas D and Wang K (2013)
The complexity, function, and applica-
tions of RNA in circulation. Front. Genet.
4:115. doi: 10.3389/fgene.2013.00115
This article was submitted to Frontiers in
Non-Coding RNA, a specialty of Frontiers
in Genetics.
Copyright © 2013 Etheridge, Gomes,
Pereira, Galas andWang. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
License, which permits use, distribution
and reproduction in other forums, pro-
vided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
Frontiers in Genetics | Non-Coding RNA June 2013 | Volume 4 | Article 115 | 8
